Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Discomfort, Lymphadenopathy, Pain, SARS-CoV-2 test
Clinical narrative: Patient reported that with previous doses shes always had real bad discomforts; then subsided or had mild pain; Patient reported that with previous doses shes always had real bad discomforts and swelling lasted a week-10 days; swelling of lymph nodes and gone within 1 week to 10 days or 2 weeks; diagnosed with COVID-19 11Jan2022 / had covid symptoms, sneezing, coughing, mucous, nausea, malaise and headache; This spontaneous case was reported by a patient and describes the occurrence of DISCOMFORT (Patient reported that with previous doses shes always had real bad discomforts), PAIN (then subsided or had mild pain), SWELLING (Patient reported that with previous doses shes always had real bad discomforts and swelling lasted a week-10 days), COVID-19 (diagnosed with COVID-19 11Jan2022 / had covid symptoms, sneezing, coughing, mucous, nausea, malaise and headache) and LYMPHADENOPATHY (swelling of lymph nodes and gone within 1 week to 10 days or 2 weeks) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 007M20A) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    Concurrent medical conditions included Food allergy (Food allergies), Hypersensitivity (Severe reactions and hypersensitivity to medications), Allergy to wool (allergies to wool), Allergy to feathers (allergies to feather) and Polymers allergy (allergies polyester).   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Nov-2021, the patient received third dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On 08-Aug-2022, received fourth dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) dosage was changed to 1 dosage form. On 11-Jan-2022, the patient experienced COVID-19 (diagnosed with COVID-19 11Jan2022 / had covid symptoms, sneezing, coughing, mucous, nausea, malaise and headache). On an unknown date, the patient experienced DISCOMFORT (Patient reported that with previous doses shes always had real bad discomforts), PAIN (then subsided or had mild pain), SWELLING (Patient reported that with previous doses shes always had real bad discomforts and swelling lasted a week-10 days) and LYMPHADENOPATHY (swelling of lymph nodes and gone within 1 week to 10 days or 2 weeks). At the time of the report, DISCOMFORT (Patient reported that with previous doses shes always had real bad discomforts) and COVID-19 (diagnosed with COVID-19 11Jan2022 / had covid symptoms, sneezing, coughing, mucous, nausea, malaise and headache) had not resolved, PAIN (then subsided or had mild pain) was resolving and SWELLING (Patient reported that with previous doses shes always had real bad discomforts and swelling lasted a week-10 days) and LYMPHADENOPATHY (swelling of lymph nodes and gone within 1 week to 10 days or 2 weeks) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Jan-2022, SARS-CoV-2 test: Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were provided.  It was reported that with previous doses patient always had real bad discomforts and swelling lasted a week-10 days and then subsided or had mild pain, swelling of lymph nodes and gone within 1 week to 10 days or 2 weeks. On 06 Jan 2022, patient had covid symptoms mostly sneezing, coughing, mucous, nausea, malaise and headache.   Treatment medications included Mitochondrial antibodies.   This case was linked to MOD-2022-693194 (Patient Link).